- Home
- MITK vs CRVS Comparison
MITK vs CRVS Comparison
Compare MITK & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITK
- CRVS
- Stock Information
- Founded
- MITK 1983
- CRVS 2014
- Country
- MITK United States
- CRVS United States
- Employees
- MITK N/A
- CRVS N/A
- Industry
- MITK Computer peripheral equipment
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- MITK Technology
- CRVS Health Care
- Exchange
- MITK Nasdaq
- CRVS Nasdaq
- Market Cap
- MITK 457.8M
- CRVS 459.0M
- IPO Year
- MITK N/A
- CRVS 2016
- Fundamental
- Price
- MITK $9.76
- CRVS $5.74
- Analyst Decision
- MITK Strong Buy
- CRVS Strong Buy
- Analyst Count
- MITK 3
- CRVS 4
- Target Price
- MITK $12.17
- CRVS $15.00
- AVG Volume (30 Days)
- MITK 353.5K
- CRVS 551.9K
- Earning Date
- MITK 08-07-2025
- CRVS 11-11-2025
- Dividend Yield
- MITK N/A
- CRVS N/A
- EPS Growth
- MITK N/A
- CRVS N/A
- EPS
- MITK 0.33
- CRVS N/A
- Revenue
- MITK $178,134,000.00
- CRVS N/A
- Revenue This Year
- MITK $4.11
- CRVS N/A
- Revenue Next Year
- MITK $7.57
- CRVS N/A
- P/E Ratio
- MITK $29.05
- CRVS N/A
- Revenue Growth
- MITK 6.98
- CRVS N/A
- 52 Week Low
- MITK $6.93
- CRVS $2.54
- 52 Week High
- MITK $11.78
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- MITK 46.08
- CRVS 55.89
- Support Level
- MITK $9.78
- CRVS $5.64
- Resistance Level
- MITK $10.48
- CRVS $6.09
- Average True Range (ATR)
- MITK 0.27
- CRVS 0.34
- MACD
- MITK -0.03
- CRVS -0.04
- Stochastic Oscillator
- MITK 23.40
- CRVS 45.10
About MITK Mitek Systems Inc.
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).